Corporate Round - Diagnomics
Investment Firm
Overview
Diagnomics operates as a Next Generation Sequencing (NGS)-based genomics company.
Announced Date
Dec 11, 2019
Funding Type
Corporate Round
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
Diagnomics raised an undisclosed amount on 2019-12-11 in Corporate Round
Diagnomics operates as a Next Generation Sequencing (NGS)-based genomics company.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 11, 2019 |  Corporate Round - Diagnomics | 1 | - | undefined |
Recent Activity
There is no recent news or activity for this profile.